Top Buy
| Security | Buy | Sell | Buy (1M) | Sell (1M) | Price | Target price ▼ | Potential |
|---|---|---|---|---|---|---|---|
| Medpace Holdings Inc | 16 | 0 | 6 | 0 | €349.70 | €418.12 | 19.566% |
| Icon plc | 24 | 0 | 3 | 0 | €304.10 | €326.21 | 7.271% |
| United Therapeutics | 24 | 0 | 3 | 0 | €311.50 | €300.00 | -3.692% |
| Alnylam Pharmace. | 44 | 0 | 0 | 0 | €216.20 | €251.80 | 16.467% |
| Charles River Labs Intl | 12 | 0 | 1 | 0 | €227.10 | €249.59 | 9.904% |
| Jazz Pharmaceuticals plc | 27 | 0 | 1 | 0 | €102.80 | €184.92 | 79.883% |
| Repligen Corp. | 14 | 0 | 1 | 0 | €148.60 | €180.49 | 21.458% |
| Ascendis Ph.sp.adr 1 Dk 1 | 1 | 0 | 0 | 0 | €124.00 | €150.00 | 20.968% |
| Neurocrine Bioscience | 36 | 0 | 5 | 0 | €130.55 | €143.34 | 9.800% |
| Ultragenyx Pharmaceutical Inc. | 23 | 1 | 1 | 0 | €41.40 | €86.28 | 108.403% |
| Dr. Reddy's Laboratories Ltd. ADR | 7 | 1 | 1 | 0 | €74.50 | €75.37 | 1.168% |
| MorphoSys AG | 7 | 0 | 0 | 0 | €67.85 | €65.00 | -4.200% |
| Ionis Pharmaceuticals Inc. | 26 | 5 | 6 | 0 | €46.04 | €56.86 | 23.506% |
| Halozyme Therapeutics Inc. | 20 | 0 | 0 | 0 | €51.64 | €55.13 | 6.766% |
| Catalent Inc. | 1 | 0 | 0 | 0 | €54.33 | €55.00 | 1.233% |
| Arrowhead Pharmaceuticals Inc. | 21 | 2 | 4 | 0 | €26.67 | €54.98 | 106.153% |
| Agios Pharmaceuticals Inc. | 8 | 1 | 0 | 1 | €43.40 | €48.75 | 12.326% |
| QIAGEN NV | 11 | 0 | 0 | 0 | €40.47 | €47.44 | 17.223% |
| PTC Therapeutics Inc. | 14 | 9 | 1 | 0 | €30.20 | €41.46 | 37.295% |
| Alkermes plc | 17 | 2 | 3 | 0 | €25.40 | €35.01 | 37.847% |
| Perrigo Co. plc | 4 | 0 | 0 | 0 | €26.17 | €35.01 | 33.761% |
| Hutchison China MediTech Ltd ADR | 4 | 0 | 0 | 0 | €18.60 | €33.46 | 79.867% |
| Xencor Inc. | 14 | 1 | 0 | 0 | €19.10 | €31.70 | 65.950% |
| Acadia Pharmaceuticals | 29 | 1 | 1 | 0 | €17.22 | €31.28 | 81.653% |
| Iovance Biotherapeutics Inc. | 22 | 2 | 0 | 0 | €8.37 | €26.25 | 213.726% |